Package | dk.kip.rkkp.fhir.ig.core |
Type | ValueSet |
Id | TreatmentRegimen |
FHIR Version | R4 |
Source | https://kip.rkkp.dk/fhir/https://build.fhir.org/ig/KIP-infrastructure/implementation-guide/ValueSet-TreatmentRegimen.html |
URL | https://kip.rkkp.dk/fhir/ValueSet/TreatmentRegimen |
Version | 2.12.0 |
Status | active |
Date | 2022-07-13T00:00:00+02:00 |
Name | TreatmentRegimen |
Title | Behandlingsplan |
Description | Behandlingsplan som beskriver specifikke codsering og planlægningen af behandling |
No resources found
CodeSystem | |
TreatmentRegimen | Treatment regimen |
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet TreatmentRegimen
https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen
Code | Display | Definition |
hydrea | Hydrea | Hydrea |
hdara_c | HdAraC | Hd-Ara-c +- supplement |
da31087 | DA inkl. 3+10, 3+8, 3+7 | DA inkl. 3+10, 3+8, 3+7 |
da31087my | DA inkl. 3+10, 3+8, 3+7 + mylotarg | DA inkl. 3+10, 3+8, 3+7 + mylotarg |
da31087mi | DA inkl. 3+10, 3+8, 3+7 + midostaurin | DA inkl. 3+10, 3+8, 3+7 + midostaurin |
flagmito | FLAG-Ida eller lign inkl FLAG, Mito-FLAG | FLAG-Ida eller lign inkl FLAG, Mito-FLAG |
flagmitovene | FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax | FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax |
idarac | IdAraC | IdAraC |
apl_mt | APL vedligehold | APL-vedligeholdsbehandling |
azacitidinmono | Azacitidin monoterapi | Azacitidin monoterapi |
blinatumomab | Blinatumunab | Blinatumomab |
vyxeos | Vyxeos | Vyxeos +- supplement |
nopho_2008 | NOPHO 2008 | NOPHO-2008 |
atoatra | ATO+ATRA | ATO+ATRA |
aida | AIDA | AIDA |
azacitidinvene | Azacitidin-venetoclax | Azacitidin-venetoclax |
toplusfem | 2+5 eller lign, eks. CT | 2+5 eller lign, eks. CT |
gilteritinib | Gilteritinib | Gilteritinib |
midostaurin_ved | Midostaurin vedligehold | Midostaurin vedligehold |
inotuzumab | Inotuzumab ozogamicin | Inotuzumab ozogamicin |
all_ved | ALL vedligehold | ALL vedligehold |
hyper_cvad | Hyper-CVAD | Hyper-CVAD |
alltogether_mt | ALLtogether | ALLtogether |
other_ikke | Anden ikke-intensiv | Anden ikke-intensiv |
other_eks | Anden eksperimentel | Anden eksperimentel |
other_semi | Anden semiintensiv (f.eks. Plan B) | Anden semiintensiv (f.eks. Plan B) |
other_int | Anden intensiv (f.eks. BISHOP, Plan A) | Anden intensiv (f.eks. BISHOP, Plan A) |
{ "resourceType": "ValueSet", "id": "TreatmentRegimen", "text": { "status": "extensions", "div": "<!-- snip (see above) -->" }, "url": "https://kip.rkkp.dk/fhir/ValueSet/TreatmentRegimen", "version": "2.12.0", "name": "TreatmentRegimen", "title": "Behandlingsplan", "status": "active", "experimental": true, "date": "2022-07-13T00:00:00+02:00", "publisher": "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S", "contact": [ { "name": "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S", "telecom": [ { "system": "url", "value": "https://trifork.com" }, { "system": "email", "value": "rbk@trifork.com" } ] } ], "description": "Behandlingsplan som beskriver specifikke codsering og planlægningen af behandling", "compose": { "include": [ { "system": "https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen", "concept": [ { "code": "hydrea", "display": "Hydrea" }, { "code": "hdara_c", "display": "HdAraC" }, { "code": "da31087", "display": "DA inkl. 3+10, 3+8, 3+7" }, { "code": "da31087my", "display": "DA inkl. 3+10, 3+8, 3+7 + mylotarg" }, { "code": "da31087mi", "display": "DA inkl. 3+10, 3+8, 3+7 + midostaurin" }, { "code": "flagmito", "display": "FLAG-Ida eller lign inkl FLAG, Mito-FLAG" }, { "code": "flagmitovene", "display": "FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax" }, { "code": "idarac", "display": "IdAraC" }, { "code": "apl_mt", "display": "APL vedligehold" }, { "code": "azacitidinmono", "display": "Azacitidin monoterapi" }, { "code": "blinatumomab", "display": "Blinatumunab" }, { "code": "vyxeos", "display": "Vyxeos" }, { "code": "nopho_2008", "display": "NOPHO 2008" }, { "code": "atoatra", "display": "ATO+ATRA" }, { "code": "aida", "display": "AIDA" }, { "code": "azacitidinvene", "display": "Azacitidin-venetoclax" }, { "code": "toplusfem", "display": "2+5 eller lign, eks. CT" }, { "code": "gilteritinib", "display": "Gilteritinib" }, { "code": "midostaurin_ved", "display": "Midostaurin vedligehold" }, { "code": "inotuzumab", "display": "Inotuzumab ozogamicin" }, { "code": "all_ved", "display": "ALL vedligehold" }, { "code": "hyper_cvad", "display": "Hyper-CVAD" }, { "code": "alltogether_mt", "display": "ALLtogether" }, { "code": "other_ikke", "display": "Anden ikke-intensiv" }, { "code": "other_eks", "display": "Anden eksperimentel" }, { "code": "other_semi", "display": "Anden semiintensiv (f.eks. Plan B)" }, { "code": "other_int", "display": "Anden intensiv (f.eks. BISHOP, Plan A)" } ] } ] } }